There is no other intervention, only clinical treatment.

OTHER5 trials

Sponsors

University of Arkansas, Shandong Cancer Hospital and Institute

Conditions

Abruptio PlacentaeBreast CancerDown SyndromeFetal Exposure Timing UnspecifiedPlacenta AccretaPlacenta Diseases

Unknown Phase

Physiological Abnormalities Associated with Down Syndrome

WithdrawnNCT03087500

University of ArkansasDown Syndrome

Start: 2017-10-01End: 2019-12-31Updated: 2024-09-03

Plasma Concentration of Biological Markers in Placental Abruption

TerminatedNCT03782168

University of ArkansasAbruptio Placentae

Start: 2019-01-31End: 2021-08-01Updated: 2024-09-03

Metabolomics Explores Biomarkers for Metastatic Breast Cancer

Shandong Cancer Hospital and InstituteBreast Cancer

Start: 2019-10-01End: 2023-02-01Target: 500Updated: 2020-03-10

Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects

CompletedNCT04422600

University of ArkansasFetal Exposure Timing Unspecified

Start: 2020-02-26End: 2023-08-01Updated: 2024-09-03

Plasma Concentration of Biological Markers in Placenta Accreta Spectrum

TerminatedNCT04525534

University of ArkansasPlacenta Accreta, Placenta Diseases

Start: 2020-08-30End: 2023-07-10Updated: 2024-09-03